All Practice Exams

100+ Free Afghanistan Medical Technology Exit Exam Practice Questions

Prepare for the Afghanistan Medical Technology / Lab Exit Exam (Institutes of Health Sciences) exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
100+ Questions
100% Free

Loading practice questions...

2026 Statistics

Key Facts: Afghanistan Medical Technology Exit Exam Exam

MCQ

Four-option multiple-choice paper on OMR sheets

Ministry of Public Health exit-exam notice

MoPH + NExA

Administered jointly by the ministry and the National Examination Authority

Ministry of Public Health exit-exam notice

Per sitting

Item count, duration, fee and pass mark are announced per sitting, not published as standing values

Ministry of Public Health exit-exam notice

Mandatory

Passing is required before the diploma practice licence is issued

Ministry of Public Health

The Afghanistan Medical Technology Exit Exam (امتحان خروجی/ایگزیت انستیتیوت‌های علوم صحی) is the national exit examination that Institute of Health Sciences diploma graduates must pass to obtain a laboratory technologist practice licence. It is announced and administered by the Ministry of Public Health with the National Examination Authority as a four-option multiple-choice paper on OMR answer sheets; the ministry publishes a subject reference for the discipline but does not publish a standing item count, duration, fee or pass mark. The official examination is administered in Dari and Pashto; this bank is an English-language MCQ study adaptation for conceptual preparation, not an official translation or a simulation of the official paper.

Sample Afghanistan Medical Technology Exit Exam Practice Questions

Try these sample questions to test your Afghanistan Medical Technology Exit Exam exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 32-year-old female presents with persistent fatigue, pallor, and brittle spoon-shaped nails (koilonychia). A complete blood count reveals hemoglobin of 7.8 g/dL, hematocrit of 24%, MCV of 68 fL, MCH of 21 pg, and an elevated Red Cell Distribution Width (RDW) of 18.5%. A peripheral blood smear demonstrates marked microcytosis, hypochromia, and pencil-shaped elliptocytes. Which set of serum iron study parameters is most definitive for confirming the underlying diagnosis?
A.Decreased serum ferritin, decreased serum iron, increased Total Iron-Binding Capacity (TIBC), and transferrin saturation < 15%
B.Increased serum ferritin, decreased serum iron, decreased Total Iron-Binding Capacity (TIBC), and normal transferrin saturation
C.Normal serum ferritin, increased serum iron, decreased Total Iron-Binding Capacity (TIBC), and transferrin saturation > 55%
D.Markedly increased serum ferritin, normal serum iron, normal Total Iron-Binding Capacity (TIBC), and elevated hemoglobin A2
Explanation: This patient presents with classic microcytic hypochromic anemia secondary to iron deficiency anemia (IDA). In iron deficiency, bone marrow iron stores are depleted first, leading to a low serum ferritin (<15-30 ng/mL), followed by a decline in circulating serum iron, a compensatory hepatic upregulation of transferrin resulting in elevated TIBC (>400 ug/dL), and a reduced transferrin saturation (Fe/TIBC < 15%). The elevated RDW reflects prominent anisocytosis, differentiating IDA from uncomplicated thalassemia trait.
2A 55-year-old strict vegan presents with progressive paresthesias in a glove-and-stocking distribution, sensory ataxia, and memory impairment. Laboratory evaluation demonstrates a macrocytic anemia with MCV of 115 fL. Examination of the Wright-stained peripheral blood smear reveals macro-ovalocytes and numerous hypersegmented neutrophils (>= 5% of neutrophils with 6 or more nuclear lobes). Which biochemical profile differentiates vitamin B12 (cobalamin) deficiency from folate deficiency?
A.Normal serum methylmalonic acid (MMA) and elevated plasma homocysteine
B.Elevated serum methylmalonic acid (MMA) and elevated plasma homocysteine
C.Elevated serum methylmalonic acid (MMA) and decreased plasma homocysteine
D.Decreased serum methylmalonic acid (MMA) and normal plasma homocysteine
Explanation: Both vitamin B12 and folate deficiencies cause megaloblastic anemia with elevated homocysteine levels due to impairment of methionine synthase. However, only vitamin B12 acts as an essential cofactor for the intramitochondrial conversion of methylmalonyl-CoA to succinyl-CoA by methylmalonyl-CoA mutase. Consequently, methylmalonic acid (MMA) is elevated exclusively in vitamin B12 deficiency, serving as a highly sensitive and specific biomarker that distinguishes it from pure folate deficiency.
3A laboratory receives an EDTA blood specimen from a 6-year-old child experiencing severe bone pain and jaundice. The medical technologist performs a sodium metabisulfite sickling test, which is positive. Hemoglobin electrophoresis on cellulose acetate at alkaline pH (8.4-8.6) demonstrates a prominent band migrating between HbA and HbA2. What molecular alteration is responsible for the altered electrophoretic mobility of Hemoglobin S?
A.Substitution of positively charged lysine for negatively charged glutamic acid at codon 6 of the beta-globin chain
B.Substitution of neutral alanine for basic histidine at codon 143 of the beta-globin chain
C.Substitution of nonpolar valine for negatively charged glutamic acid at codon 6 of the beta-globin chain
D.Complete deletion of two alpha-globin structural genes on chromosome 16
Explanation: Sickle cell hemoglobin (HbS) results from a point mutation (GAG -> GTG) in the HBB gene, substituting neutral, hydrophobic valine for negatively charged glutamic acid at position 6 of the beta-globin polypeptide chain. Because HbS loses two negative charges per tetramer compared to HbA, it migrates more slowly toward the positive anode during alkaline electrophoresis (pH 8.4-8.6), positioning itself between HbA and the cathodic HbA2/C band.
4An asymptomatic 24-year-old male undergoing routine pre-employment screening is found to have RBC: 6.2 x 10^12/L, Hemoglobin: 11.5 g/dL, Hematocrit: 35%, MCV: 62 fL, MCH: 20 pg, and RDW: 12.2%. The Mentzer index (MCV / RBC count in millions) is calculated as 10.0. Peripheral blood film shows microcytes, frequent codocytes (target cells), and basophilic stippling. Which diagnostic finding is most characteristic of beta-thalassemia minor (trait)?
A.Serum ferritin is severely decreased (< 10 ng/mL) and free erythrocyte protoporphyrin is elevated
B.Direct Antiglobulin Test (DAT) is strongly positive with anti-IgG and anti-C3d reagents
C.Hemoglobin electrophoresis reveals complete absence of Hemoglobin A and 95% Hemoglobin F
D.Serum ferritin is within normal reference limits and quantitative HPLC reveals HbA2 levels of 4.0% to 7.0%
Explanation: Beta-thalassemia minor (trait) is characterized by mild microcytic hypochromic anemia with an elevated or borderline high RBC count ('microcytic erythrocytosis'), yielding a low Mentzer index (< 13), normal RDW, and normal serum iron/ferritin stores. Quantitative high-performance liquid chromatography (HPLC) or capillary electrophoresis confirms the diagnosis by demonstrating an elevated Hemoglobin A2 (alpha-2, delta-2) level typically between 3.5% and 7.0% (reference: 1.5-3.5%) due to delta-chain compensation.
5A 28-year-old male develops sudden dark tea-colored urine, scleral icterus, and fatigue 48 hours after initiating primaquine therapy for Plasmodium vivax malaria. A Supravital stain (crystal violet) on fresh uncoagulated blood reveals distinct, round intraerythrocytic inclusions attached to the internal surface of the red cell membrane (Heinz bodies). What is the underlying pathophysiology and the most appropriate timing for definitive enzyme quantification?
A.Glucose-6-phosphate dehydrogenase (G6PD) deficiency; quantitative enzyme assay should be performed 2 to 3 months after resolution of the acute hemolytic episode
B.Pyruvate kinase (PK) deficiency; quantitative enzyme assay must be performed immediately during peak reticulocytosis
C.Paroxysmal Nocturnal Hemoglobinuria (PNH); flow cytometric CD55/CD59 testing must be performed within 24 hours
D.Methemoglobin reductase deficiency; assay should be conducted after administering methylene blue
Explanation: In G6PD deficiency (an X-linked recessive disorder), erythrocytes lack sufficient NADPH to maintain reduced glutathione (GSH), rendering hemoglobin susceptible to oxidative precipitation into Heinz bodies when exposed to oxidant drugs like primaquine. Testing G6PD enzyme levels during or immediately following an acute hemolytic episode can yield false-negative (normal) results because older, enzyme-deficient red cells have already hemolyzed, leaving behind younger reticulocytes with higher G6PD activity. Definitive testing must be delayed 2-3 months until erythropoiesis stabilizes.
6A 62-year-old female with systemic lupus erythematosus presents with acute severe anemia, spherocytosis on peripheral blood smear, and elevated unconjugated bilirubin. The laboratory performs a Direct Antiglobulin Test (DAT) to evaluate suspected Autoimmune Hemolytic Anemia (AIHA). Which result pattern is most typically observed in Warm Autoimmune Hemolytic Anemia (WAIHA)?
A.Polyspecific AHG positive, anti-IgG negative, anti-C3d strongly positive only, with thermal amplitude optimal at 0-4°C
B.Polyspecific AHG positive, anti-IgG positive (often with anti-C3d positive), exhibiting optimal antibody reactivity at 37°C
C.Polyspecific AHG negative, Indirect Antiglobulin Test (IAT) positive only at room temperature (22°C)
D.Biphasic hemolysin binding at 4°C and lysing autologous erythrocytes only upon warming to 37°C in the presence of complement
Explanation: Warm Autoimmune Hemolytic Anemia (WAIHA) accounts for 70-80% of AIHA cases and is mediated by warm-reactive polyclonal IgG antibodies (frequently with specificity against Rh complex antigens) that bind maximally to red blood cells at 37°C. The Direct Antiglobulin Test (DAT) is characteristically positive with anti-IgG alone (20-40%) or both anti-IgG and anti-C3d (50-60%), leading to extravascular splenic macrophage phagocytosis and spherocytosis.
7A 16-year-old boy presents with splenomegaly, recurrent mild jaundice, and cholelithiasis. The laboratory report reveals Hb: 10.2 g/dL, MCV: 80 fL, and MCHC: 37.5 g/dL. Numerous microspherocytes lacking central pallor are observed on the blood film. An Osmotic Fragility Test is performed. What physiological mechanism explains the increased osmotic fragility observed in Hereditary Spherocytosis (HS)?
A.Increased membrane surface area-to-volume ratio caused by lipid accumulation, shifting the lysis curve to the right
B.Deficiency of glucose-6-phosphate dehydrogenase causing cellular dehydration and hyperchromia
C.Decreased surface area-to-volume ratio due to skeletal membrane protein defects (ankyrin, spectrin, band 3), causing early lysis in hypotonic saline
D.Defective alpha-globin synthesis causing precipitation of beta-chain tetramers that stiffen the red cell membrane
Explanation: Hereditary Spherocytosis is caused by qualitative or quantitative mutations in red cell membrane cytoskeletal proteins (most commonly ankyrin-1, followed by beta-spectrin, band 3, and protein 4.2). This leads to uncoupling of the lipid bilayer, progressive loss of membrane surface area through microvesiculation, and formation of rigid spherical erythrocytes with a severely decreased surface area-to-volume ratio and high MCHC (>36 g/dL). In the osmotic fragility test, these spherocytes cannot tolerate fluid influx and lyse at higher concentrations of NaCl compared to normal biconcave red cells.
8A 45-year-old patient presents with acute gingival bleeding, fever, and generalized petechiae. Bone marrow aspirate reveals hypercellular marrow with 45% blasts exhibiting abundant cytoplasm, delicate chromatin, prominent nucleoli, and distinct needle-like crystalline cytoplasmic inclusions (Auer rods). Cytochemical staining demonstrates strong positivity for Myeloperoxidase (MPO) and Sudan Black B (SBB). What is the definitive lineage diagnosis?
A.B-cell Acute Lymphoblastic Leukemia (B-ALL)
B.T-cell Acute Lymphoblastic Leukemia (T-ALL)
C.Chronic Lymphocytic Leukemia (CLL)
D.Acute Myeloid Leukemia (AML)
Explanation: The presence of Auer rods (fused primary azurophilic granules) is pathognomonic for malignant neoplasms of myeloid lineage. Strong cytochemical reactivity with Myeloperoxidase (MPO) and Sudan Black B (SBB), alongside >= 20% blasts in the bone marrow, confirms the diagnosis of Acute Myeloid Leukemia (AML). Lymphoblasts in ALL are strictly negative for Auer rods, MPO, and SBB.
9A 4-year-old child presents with lethargy, bone pain, hepatosplenomegaly, and generalized lymphadenopathy. CBC shows WBC of 68 x 10^9/L with 85% small-to-medium sized blasts having scant cytoplasm, high nuclear-to-cytoplasmic (N:C) ratio, and indistinct nucleoli. Cytochemistry reveals that the blasts are negative for Myeloperoxidase and Sudan Black B, but show coarse block-like positivity with Periodic Acid-Schiff (PAS). Flow cytometry confirms positivity for Terminal Deoxynucleotidyl Transferase (TdT) and CD10 (CALLA). What is the diagnosis?
A.B-cell Acute Lymphoblastic Leukemia (B-ALL)
B.Acute Monocytic Leukemia (AML-M5)
C.Hairy Cell Leukemia (HCL)
D.Chronic Myelogenous Leukemia in chronic phase
Explanation: B-cell Acute Lymphoblastic Leukemia (B-ALL) is the most common pediatric malignancy. Lymphoblasts characteristically exhibit coarse chunk/block-like cytoplasmic positivity with PAS (reflecting glycogen aggregation), are MPO/SBB negative, and express nuclear Terminal Deoxynucleotidyl Transferase (TdT, a marker of immature lymphoid progenitors) along with CD10 (Common ALL Antigen / CALLA), CD19, and CD22.
10A 48-year-old male presents with massive splenomegaly, dragging left upper quadrant fullness, and a total leukocyte count of 145 x 10^9/L. The peripheral blood differential reveals the entire spectrum of granulocytic maturation: 48% segmented neutrophils, 18% band forms, 14% metamyelocytes, 12% myelocytes, 3% promyelocytes, 1% blasts, 3% eosinophils, and 1% basophils. Which laboratory investigation is most crucial to differentiate Chronic Myelogenous Leukemia (CML) from a severe benign Leukemoid Reaction?
A.Leukocyte Alkaline Phosphatase (LAP / NAP) score is markedly elevated (> 160) in CML, and cytogenetics reveals trisomy 21
B.Leukocyte Alkaline Phosphatase (LAP / NAP) score is markedly decreased (often 0-20) in CML, and cytogenetics reveals t(9;22)(q34;q11.2) / BCR-ABL1
C.Serum vitamin B12 levels are severely decreased in CML and elevated in leukemoid reaction
D.Direct Antiglobulin Test (DAT) is positive in CML and negative in leukemoid reaction
Explanation: Chronic Myelogenous Leukemia (CML) is a myeloproliferative neoplasm driven by the Philadelphia chromosome, representing the reciprocal translocation t(9;22)(q34;q11.2) that creates the constitutively active BCR-ABL1 tyrosine kinase fusion gene. A fundamental cytochemical discriminator is the Leukocyte Alkaline Phosphatase (LAP) score, which is characteristically low or absent (0-20; reference: 20-100) in CML neutrophils due to clonal enzyme deficiency, whereas a benign leukemoid reaction exhibits a high LAP score (>100-150) and lacks the BCR-ABL1 translocation.

About the Afghanistan Medical Technology Exit Exam Exam

The Afghanistan Medical Technology Exit Exam (امتحان دولتی تکنالوژی طبی و لابراتوار) is the statutory national exit and licensing examination administered by NExA for medical laboratory graduates to obtain professional practice credentials.

Assessment

Four-option multiple-choice paper marked on OMR answer sheets, announced per sitting by the Ministry of Public Health with NExA and set against the ministry's published discipline reference covering Hematology and Blood Banking, Microbiology and Parasitology, Clinical Biochemistry, Histopathology and Cytology, Immunology and Serology, and Laboratory Safety and Quality Control. The official item count and session length are not published.

Time Limit

Not published by the Ministry of Public Health or the National Examination Authority

Passing Score

Set by the Ministry of Public Health for each sitting; no standing pass mark published

Exam Fee

Set per sitting by the Ministry of Public Health; the current fee is not published (Ministry of Public Health (MoPH — انستیتوت های علوم صحی) and National Examination Authority (NExA))

Afghanistan Medical Technology Exit Exam Exam Content Outline

25 practice items in this bank

Hematology & Immunohematology

Complete blood counts, blood smear morphology, coagulation cascades, ABO/Rh typing, and crossmatching.

25 practice items in this bank

Medical Microbiology & Parasitology

Bacterial staining, culture isolation, antibiotic sensitivity testing, and microscopic parasite identification.

20 practice items in this bank

Clinical Biochemistry & Body Fluids

Renal/liver panels, serum electrolytes, glucose testing, urinalysis, and cerebrospinal fluid examination.

10 practice items in this bank

Histopathology & Cytology

Tissue fixation, paraffin microtomy, H&E staining, and cytological preparation techniques.

10 practice items in this bank

Immunology & Serological Tests

Agglutination tests, ELISA methodologies, rapid viral screening kits, and serodiagnosis.

10 practice items in this bank

Laboratory Safety & Quality Control

Biosafety rules, autoclave sterilization, Westgard quality control rules, and equipment calibration.

How to Pass the Afghanistan Medical Technology Exit Exam Exam

What You Need to Know

  • Passing score: Set by the Ministry of Public Health for each sitting; no standing pass mark published
  • Assessment: Four-option multiple-choice paper marked on OMR answer sheets, announced per sitting by the Ministry of Public Health with NExA and set against the ministry's published discipline reference covering Hematology and Blood Banking, Microbiology and Parasitology, Clinical Biochemistry, Histopathology and Cytology, Immunology and Serology, and Laboratory Safety and Quality Control. The official item count and session length are not published.
  • Time limit: Not published by the Ministry of Public Health or the National Examination Authority
  • Exam fee: Set per sitting by the Ministry of Public Health; the current fee is not published

Keys to Passing

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Afghanistan Medical Technology Exit Exam Study Tips from Top Performers

1Review the morphology of peripheral blood cells in iron deficiency anemia, megaloblastic anemia, and acute leukemias.
2Memorize biochemical reactions (oxidase, catalase, indole, citrate, urease) used to differentiate gram-negative enterobacteriaceae.
3Understand the principles and interpretation of Westgard multirules (1-2s, 1-3s, 2-2s, R-4s) in clinical quality control.

Frequently Asked Questions

What is the format of the Medical Technology Exit Exam?

The examination is a 100-item multiple-choice test on OMR sheets administered over a 2-hour period under NExA supervision.

Who must sit the Medical Technology Exit Exam?

Graduates of accredited 3-year Medical Laboratory Technology diploma programs from public and private health sciences institutes in Afghanistan.

What is the passing mark and exam cost?

The Ministry of Public Health sets the pass mark and registration fee for each announced sitting; neither is published as a standing value.

What language is the official examination conducted in?

The official exam is in Dari and Pashto. Our study bank provides an English-language MCQ practice adaptation for clinical laboratory concept review.